CROI 2020 Program and Conference Information

Oral Sessions




Ballroom C 4:00 AM - 6:00 AM Target Audience: This session is directed to clinicians, public health practitioners, and scientists who are interested in understanding the current global epidemiology, clinical interventions, public health implications, prevention, and financing of hepatitis C. Level of Knowledge: It is assumed that the participants are familiar with basic infectious disease, clinical, and public health terminology and context. Objectives: At the completion of the session, participants will be able to: • Describe the global epidemiology of hepatitis C infection • Explain vertical hepatitis C transmission • Describe examples of successful programs for the elimination of hepatitis C infection Conveners Risha Irvin , Johns Hopkins University, Baltimore, MD, USA Marina Klein , McGill University Health Centre Research Institute, Montreal, QC, Canada 161 GLOBAL EPIDEMIOLOGY OF HEPATITIS C Yvan Hutin , World Health Organization, Geneva, Switzerland 4:00

162 MODELING AND EXAMPLES OF HCV ELIMINATION: POSSIBILITIES, ACHIEVEMENTS, AND NEXT STEPS Natasha Martin , University of California San Diego, San Diego, CA, USA 163 VERTICAL HEPATITIS C TRANSMISSION: DÉJÀ VU ALL OVER AGAIN? Ali Judd , University College London, London, UK 164 HEPATITIS C TREATMENT ON A SHOESTRING Isabelle Andrieux-Meyer , Drugs for Neglected Diseases Initiative, Geneva, Switzerland 4:30 5:00 5:30

Oral Sessions • Wednesday

CROI 2020 65

Made with FlippingBook - professional solution for displaying marketing and sales documents online